HJLIW -

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.1405
0.0000 (0.00%)
At close: 3:57PM EST
Stock chart is not supported by your current browser
Previous Close0.1405
Open0.1405
Bid0.1282 x 3000
Ask0.1400 x 1200
Day's Range0.1405 - 0.1405
52 Week Range0.0220 - 0.4800
Volume450
Avg. Volume1,169
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • ACCESSWIRE

    VenoValve Abstract Published in January 2020 Edition of Journal of Vascular Surgery

    IRVINE, CA / ACCESSWIRE / December 20, 2019 / Hancock Jaffe Laboratories, Inc. (HJLI)(HJLIW), a developer of medical devices that restore cardiac and vascular health, announced today that an abstract entitled Results of First-in-Human Implantation of a Prosthetic Venous Valve has been published in the January 2020 edition of the Journal of Vascular Surgery®. A presentation from the abstract will be delivered by Dr. Jorge Hernando Ulloa, the Principal Investigator for HJLI's first-in-man VenoValve study in Bogota, Colombia, at the 44th Annual Meeting of the Southern Association for Vascular Surgery ("SAVS"), which will take place January 8 to January 11 in Palm Beach, Florida.